| 靶点: |
IC50: 3 nM (human SGK1, ATP=500 μM), 253 nM (mouse SGK1, ATP=500 μM), 358 nM (rat SGK1, ATP=500 μM) |
| 参考文献: |
1. Nis Halland, et al. Rational Design of Highly Potent, Selective, and Bioavailable SGK1 Protein Kinase Inhibitors for the Treatment of Osteoarthritis. J Med Chem. 2022 Jan 27;65(2):1567-1584. |
| 保存条件: |
避光,-80℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.931 ml |
9.653 ml |
19.307 ml |
| 5 mM |
0.386 ml |
1.931 ml |
3.861 ml |
| 10 mM |
0.193 ml |
0.965 ml |
1.931 ml |
| 50 mM |
0.039 ml |
0.193 ml |
0.386 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |